Lisa McCloskey

2.8k total citations · 3 hit papers
16 papers, 1.9k citations indexed

About

Lisa McCloskey is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lisa McCloskey has authored 16 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Lisa McCloskey's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Immune Cell Function and Interaction (6 papers) and Pediatric health and respiratory diseases (5 papers). Lisa McCloskey is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Immune Cell Function and Interaction (6 papers) and Pediatric health and respiratory diseases (5 papers). Lisa McCloskey collaborates with scholars based in United States and Slovakia. Lisa McCloskey's co-authors include Jeffrey L. Curtis, Christine M. Freeman, Gary B. Huffnagle, John R. Erb‐Downward, Robert P. Dickson, Fernando J. Martínez, MeiLan K. Han, Deborah Thompson, Lindsay Schmidt and Vincent B. Young and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Lisa McCloskey

16 papers receiving 1.9k citations

Hit Papers

Analysis of the Lung Microbiome in the “Healthy” Smoker a... 2011 2026 2016 2021 2011 2015 2017 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa McCloskey United States 13 992 879 520 374 372 16 1.9k
Aaron Ervine United Kingdom 5 706 0.7× 549 0.6× 411 0.8× 232 0.6× 476 1.3× 7 1.4k
Len W. Poulter United Kingdom 6 712 0.7× 537 0.6× 412 0.8× 261 0.7× 502 1.3× 6 1.8k
Shu Mei Teo Australia 15 843 0.8× 422 0.5× 404 0.8× 458 1.2× 466 1.3× 36 1.8k
Céline Pattaroni Australia 16 770 0.8× 273 0.3× 291 0.6× 242 0.6× 227 0.6× 30 1.5k
Cara Bossley United Kingdom 18 771 0.8× 1.5k 1.7× 631 1.2× 393 1.1× 1.8k 4.7× 49 3.0k
David J. Serisier Australia 20 544 0.5× 1.6k 1.9× 349 0.7× 544 1.5× 233 0.6× 49 2.1k
D. Mok Australia 16 675 0.7× 336 0.4× 351 0.7× 474 1.3× 389 1.0× 26 1.6k
Alexa A. Pragman United States 17 672 0.7× 597 0.7× 244 0.5× 224 0.6× 158 0.4× 29 1.4k
Eric Bernasconi Switzerland 16 352 0.4× 239 0.3× 142 0.3× 238 0.6× 87 0.2× 27 1.0k
Shean Aujla United States 10 198 0.2× 495 0.6× 206 0.4× 318 0.9× 653 1.8× 15 2.2k

Countries citing papers authored by Lisa McCloskey

Since Specialization
Citations

This map shows the geographic impact of Lisa McCloskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa McCloskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa McCloskey more than expected).

Fields of papers citing papers by Lisa McCloskey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa McCloskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa McCloskey. The network helps show where Lisa McCloskey may publish in the future.

Co-authorship network of co-authors of Lisa McCloskey

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa McCloskey. A scholar is included among the top collaborators of Lisa McCloskey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa McCloskey. Lisa McCloskey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stolberg, Valerie R., et al.. (2021). Human lung cDC1 drive increased perforin-mediated NK cytotoxicity in chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 321(6). L1183–L1193. 12 indexed citations
2.
Erb‐Downward, John R., Nicole R. Falkowski, Jennifer D’Souza, et al.. (2020). Critical Relevance of Stochastic Effects on Low-Bacterial-Biomass 16S rRNA Gene Analysis. mBio. 11(3). 31 indexed citations
3.
Stolberg, Valerie R., et al.. (2019). Perforin Inhibition Blocks NK-Mediated In Vitro Killing of Human Lung Epithelial Cells in COPD. A4546–A4546. 1 indexed citations
4.
Finch, Donna K., Valerie R. Stolberg, John Ferguson, et al.. (2018). Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα. American Journal of Respiratory and Critical Care Medicine. 198(9). 1140–1150. 39 indexed citations
5.
Dickson, Robert P., John R. Erb‐Downward, Christine M. Freeman, et al.. (2017). Bacterial Topography of the Healthy Human Lower Respiratory Tract. mBio. 8(1). 339 indexed citations breakdown →
6.
McCubbrey, Alexandra L., Joshua D. Nelson, Valerie R. Stolberg, et al.. (2015). MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. The Journal of Immunology. 196(3). 1366–1375. 34 indexed citations
7.
Dickson, Robert P., John R. Erb‐Downward, Christine M. Freeman, et al.. (2015). Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography. Annals of the American Thoracic Society. 12(6). 821–830. 366 indexed citations breakdown →
8.
Freeman, Christine M., Cristina Martínez, Jill C. Todt, et al.. (2015). Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood. Respiratory Research. 16(1). 94–94. 49 indexed citations
9.
Freeman, Christine M., Valerie R. Stolberg, Fernando J. Martínez, et al.. (2014). Human CD56+ Cytotoxic Lung Lymphocytes Kill Autologous Lung Cells in Chronic Obstructive Pulmonary Disease. PLoS ONE. 9(7). e103840–e103840. 48 indexed citations
10.
Freeman, Christine M., Alexandra L. McCubbrey, Joshua D. Nelson, et al.. (2014). Basal Gene Expression by Lung CD4+ T Cells in Chronic Obstructive Pulmonary Disease Identifies Independent Molecular Correlates of Airflow Obstruction and Emphysema Extent. PLoS ONE. 9(5). e96421–e96421. 19 indexed citations
11.
Freeman, Christine M., Fernando J. Martínez, MeiLan K. Han, et al.. (2013). Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respiratory Research. 14(1). 13–13. 59 indexed citations
12.
Erb‐Downward, John R., Deborah Thompson, MeiLan K. Han, et al.. (2011). Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD. PLoS ONE. 6(2). e16384–e16384. 726 indexed citations breakdown →
13.
Freeman, Christine M., MeiLan K. Han, Fernando J. Martínez, et al.. (2010). Cytotoxic Potential of Lung CD8+ T Cells Increases with Chronic Obstructive Pulmonary Disease Severity and with In Vitro Stimulation by IL-18 or IL-15. The Journal of Immunology. 184(11). 6504–6513. 89 indexed citations
14.
Erb‐Downward, John R., Deborah Thompson, MeiLan K. Han, et al.. (2010). Analysis Of The Microbiome Of The Normal And COPD Lung. A5628–A5628. 1 indexed citations
15.
Freeman, Christine M., Fernando J. Martínez, MeiLan K. Han, et al.. (2009). Lung Dendritic Cell Expression of Maturation Molecules Increases with Worsening Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 180(12). 1179–1188. 92 indexed citations
16.
Freeman, Christine M., Fernando J. Martínez, MeiLan K. Han, et al.. (2009). Lung Dendritic Cell Expression of Maturation Molecules Increases with Worsening COPD. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026